1887

Abstract

Inhibition of protein synthesis is a common mechanism by which bacterial and plant toxins injure human cells. Examples of toxins that inhibit protein synthesis include shiga toxins of , diphtheria toxin, exotoxin A and the plant toxin ricin. In order to facilitate studies on toxin pathogenesis and to enable screening for inhibitors of toxin action, a quantitative and highly sensitive assay for the action of these toxins on mammalian cells was developed. The cDNA encoding destabilized luciferase was cloned into an adenoviral expression plasmid and a high-titre viral stock was prepared. Following transduction of Vero cells, luciferase expression was found to be linear with respect to viral multiplicity of infection. Luciferase expression by as few as 10 cells was readily detected. Treatment of transduced cells with either cycloheximide or shiga toxin resulted in a decrease in luciferase activity, with a half-life ranging from 1 to 2 h. Inhibition of luciferase expression was evident at toxin concentrations as low as 1 pg ml. The assay was adapted for use in 24-, 96- and 384-well plates, enabling rapid processing of large numbers of samples. Using this approach, susceptibility of Vero, Hep2, Chang, A549, COS-1 and HeLa cells to three different toxins was determined. These results demonstrate that the luciferase-based assay is applicable to the study of numerous cell types, is quantitative, highly sensitive and reproducible. These features will facilitate studies on pathophysiology of toxin-mediated diseases and allow high-throughput screening for inhibitors of cytotoxicity.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46143-0
2005-11-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/11/JM541104.html?itemId=/content/journal/jmm/10.1099/jmm.0.46143-0&mimeType=html&fmt=ahah

References

  1. Balint G. A. 1974; Ricin: the toxic protein of castor oil seeds. Toxicology 2:77–102 [CrossRef]
    [Google Scholar]
  2. Boulton F. 2003; Which bio-weapons might be used by terrorists against the United Kingdom?. Med Confl Surviv 19:326–330 [CrossRef]
    [Google Scholar]
  3. Bradberry S. M., Dickers K. J., Rice P., Griffiths G. D., Vale J. A. 2003; Ricin poisoning. Toxicol Rev 22:65–70 [CrossRef]
    [Google Scholar]
  4. Clarke S. C. 2002; Bioterrorism: an overview. Br J Biomed Sci 59:232–234
    [Google Scholar]
  5. Debinski W., Obiri N. I., Pastan I., Puri R. K. 1995; A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4. J Biol Chem 270:16775–16780 [CrossRef]
    [Google Scholar]
  6. DeGrandis S., Law H., Brunton J., Gyles C., Lingwood C. A. 1989; Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem 264:12520–12525
    [Google Scholar]
  7. de Wet J. R., Wood K. V., DeLuca M., Helinski D. R., Subramani S. 1987; Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7:725–737
    [Google Scholar]
  8. Dittmann S., Wharton M., Vitek C. & 15 other authors; 2000; Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 181:Suppl 1S10–S22
    [Google Scholar]
  9. Doring G., Muller E. 1989; Different sensitivity of Pseudomonas aeruginosa exotoxin A and diphtheria toxin to enzymes from polymorphonuclear leukocytes. Microb Pathog 6:287–295 [CrossRef]
    [Google Scholar]
  10. Elliott S. P., Yu M., Xu H., Haslam D. B. 2003; Forssman synthetase expression results in diminished shiga toxin susceptibility: a role for glycolipids in determining host-microbe interactions. Infect Immun 71:6543–6552 [CrossRef]
    [Google Scholar]
  11. Endo Y., Tsurugi K. 1988; The RNA N -glycosidase activity of ricin A-chain.The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. J Biol Chem 263:8735–8739
    [Google Scholar]
  12. Endo Y., Mitsui K., Motizuki M., Tsurugi K. 1987; The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes.The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 262:5908–5912
    [Google Scholar]
  13. Franz D. R., Zajtchuk R. 2000; Biological terrorism: understanding the threat, preparation, and medical response. Dis Mon 46:125–190
    [Google Scholar]
  14. Iglewski B. H., Kabat D. 1975; NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin. Proc Natl Acad Sci U S A 72:2284–2288 [CrossRef]
    [Google Scholar]
  15. Keusch G. T., Jacewicz M., Acheson D. W., Donohue-Rolfe A., Kane A. V., McCluer R. H. 1995; Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect Immun 63:1138–1141
    [Google Scholar]
  16. Laithwaite J. E., Benn S. J., Yamate J., FitzGerald D. J., LaMarre J. 1999; Enhanced macrophage resistance to Pseudomonas exotoxin A is correlated with decreased expression of the low-density lipoprotein receptor-related protein. Infect Immun 67:5827–5833
    [Google Scholar]
  17. Li X., Zhao X., Fang Y., Jiang X., Duong T., Fan C., Huang C. C., Kain S. R. 1998; Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem 273:34970–34975 [CrossRef]
    [Google Scholar]
  18. Lyczak J. B., Cannon C. L., Pier G. B. 2000; Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2:1051–1060 [CrossRef]
    [Google Scholar]
  19. Madsen J. M. 2001; Toxins as weapons of mass destruction.A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med 21:593–605
    [Google Scholar]
  20. O'Brien A. D., Tesh V. L., Donohue-Rolfe A., Jackson M. P., Olsnes S., Sandvig K., Lindberg A. A., Keusch G. T. 1992; Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol 180:65–94
    [Google Scholar]
  21. Obrig T. G., Moran T. P., Colinas R. J. 1985; Ribonuclease activity associated with the 60S ribosome-inactivating proteins ricin A, phytolaccin and Shiga toxin. Biochem Biophys Res Commun 130:879–884 [CrossRef]
    [Google Scholar]
  22. Obrig T. G., Moran T. P., Brown J. E. 1987; The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J 244:287–294
    [Google Scholar]
  23. Obrig T. G., Louise C. B., Lingwood C. A., Boyd B., Barley-Maloney L., Daniel T. O. 1993; Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268:15484–15488
    [Google Scholar]
  24. Ohmi K., Kiyokawa N., Takeda T., Fujimoto J. 1998; Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem Biophys Res Commun 251:137–141 [CrossRef]
    [Google Scholar]
  25. Olsnes S. 2004; The history of ricin, abrin and related toxins. Toxicon 44:361–370 [CrossRef]
    [Google Scholar]
  26. Pappenheimer A. M. Jr 1977; Diphtheria toxin. Annu Rev Biochem 46:69–94 [CrossRef]
    [Google Scholar]
  27. Pappenheimer A. M. Jr, Brown R. 1968; Studies on the mode of action of diphtheria toxin.VI. Site of the action of toxin in living cells. J Exp Med 127:1073–1086 [CrossRef]
    [Google Scholar]
  28. Pickering L. K., Obrig T. G., Stapleton F. B. 1994; Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli . Pediatr Infect Dis J 13:459–475 [CrossRef]
    [Google Scholar]
  29. Puri R. K., Leland P., Obiri N. I., Husain S. R., Kreitman R. J., Haas G. P., Pastan I., Debinski W. 1996; Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Blood 87:4333–4339
    [Google Scholar]
  30. Rechsteiner M. 1990; PEST sequences are signals for rapid intracellular proteolysis. Semin Cell Biol 1:433–440
    [Google Scholar]
  31. Reisbig R., Olsnes S., Eiklid K. 1981; The cytotoxic activity of Shigella toxin.Evidence for catalytic inactivation of the 60 S ribosomal subunit. J Biol Chem 256:8739–8744
    [Google Scholar]
  32. Sekino T., Kiyokawa N., Taguchi T. & 12 other authors; 2004; Characterization of a shiga-toxin 1-resistant stock of vero cells. Microbiol Immunol 48:377–387 [CrossRef]
    [Google Scholar]
  33. Suhan M. L., Hovde C. J. 1998; Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity. Infect Immun 66:5252–5259
    [Google Scholar]
  34. Tarr P. I. 1995; Escherichia coli O157 : H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 20:1–8 [CrossRef]
    [Google Scholar]
  35. Valdivieso-Garcia A., MacLeod D. L., Clarke R. C., Gyles C. L., Lingwood C., Boyd B., Durette A. 1996; Comparative cytotoxicity of purified Shiga-like toxin-IIe on porcine and bovine aortic endothelial and human colonic adenocarcinoma cells. J Med Microbiol 45:331–337 [CrossRef]
    [Google Scholar]
  36. Ward G. E., Carey K. L., Westwood N. J. 2002; Using small molecules to study big questions in cellular microbiology. Cell Microbiol 4:471–482 [CrossRef]
    [Google Scholar]
  37. Yu M., Haslam D. 2005; Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3. Infect Immun 73:2524–2532 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46143-0
Loading
/content/journal/jmm/10.1099/jmm.0.46143-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error